Could this new test change how we treat colorectal cancer?

We recently shared a look at how research at Baylor Scott & White is helping to crack the code to detect colon cancer earlier. Detection, however, isn’t the only variable to consider where colon cancer is concerned. Once diagnosed with the disease, attention turns to treatment options. For T1 colorectal cancer (CRC) patients, in particular, … Continue reading Could this new test change how we treat colorectal cancer?

Unlocking the potential of biomarkers for colorectal cancer

1 in 21. Those are the current odds for men of developing colorectal cancer in their lifetime. The odds only slightly improve for women, with the current risk rate at 1 in 23. For people suffering from ulcerative colitis, the risk of developing colon cancer becomes even higher. Fighting this deadly cancer, which is expected … Continue reading Unlocking the potential of biomarkers for colorectal cancer

Pancreatic cancer: New research opens door to groundbreaking early detection system

Baylor Scott & White Research Institute (BSWRI) unveiled its latest endeavor aimed at taking the fight against pancreatic cancer to a new level. BSWRI received a $5.13 million federal grant from the NIH to continue its work to develop an early detection system for pancreatic cancer, the nation’s third-leading cause of cancer-related death. As more … Continue reading Pancreatic cancer: New research opens door to groundbreaking early detection system

Foster daughter inspires triathlete to swim for cancer research

Allison Field dreams of a cancer-free world. That’s why she’s doing her part to support cancer research by swimming for the cause with Swim Across America. She draws inspiration and courage from her foster daughter, Deanna Stearn. Deanna came to live with Allison and her then husband when she was 16 years old. She and … Continue reading Foster daughter inspires triathlete to swim for cancer research

Ovarian Cancer’s Vulnerability Exposed: Clinical Trial Offers New Hope

Targeted therapy for ovarian cancer has been an elusive goal for researchers for many years because ovarian cancer is a heterogeneous disease, exhibiting a plethora of genetic alterations. In a small percentage of patients, the cancer is found to be hereditary. In these patients, mutations in the BRCA gene lead to an increased risk of ovarian, … Continue reading Ovarian Cancer’s Vulnerability Exposed: Clinical Trial Offers New Hope